XBiotech (XBIT) Enterprise Value (2014 - 2026)
XBiotech (XBIT) posted quarterly Enterprise Value of -$125.6 million for Q4 2025, up 27.26% year-over-year from -$98.7 million in Q4 2024, and up 14.77% quarter-over-quarter from -$147.4 million in Q3 2025.
XBiotech (XBIT) Enterprise Value (2014 - 2026) Analysis & Trends
XBiotech's Enterprise Value history runs 12 years deep, the most recent figure standing at -$125.6 million for Q4 2025.
- In Q4 2025, Enterprise Value rose 27.26% year-over-year to -$125.6 million; the TTM figure through Dec 2025 stood at -$125.6 million (up 27.26% YoY), while the FY2025 annual figure was -$125.6 million, up 27.26% from the prior year.
- Enterprise Value for Q4 2025 stood at -$125.6 million, up from -$147.4 million in the prior quarter.
- The five-year high for Enterprise Value was -$125.6 million in Q4 2025, with the low at -$315.3 million in Q2 2021.
- The 5-year median for Enterprise Value is -$203.5 million (2023), against an average of -$203.7 million.
- The sharpest annual moves came in 2021 and 2022: Enterprise Value tumbled 37.26% in 2021, then grew 28.39% in 2022.
- XBiotech's Enterprise Value stood at -$237.0 million in 2021, then increased by 8.23% to -$217.5 million in 2022, then rose by 8.03% to -$200.0 million in 2023, then advanced by 13.67% to -$172.7 million in 2024, then rose by 27.26% to -$125.6 million in 2025.
- Business Quant data shows XBIT's Enterprise Value at -$125.6 million in Q4 2025, -$147.4 million in Q3 2025, and -$152.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | -7.85 Bn |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | -7.99 Bn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | -5.18 Bn |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -5.14 Bn |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | -5.10 Bn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | -3.31 Bn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -1.16 Bn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 2.12 Bn |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -18.39 Bn |
| 10 | XBiotech | 68.90 Mn | 68.90 Mn | - | -109.53 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -109.53 Mn |
| Dec 31, 2025 | -125.60 Mn |
| Sep 30, 2025 | -147.37 Mn |
| Jun 30, 2025 | -152.94 Mn |
| Mar 31, 2025 | -155.90 Mn |
| Dec 31, 2024 | -172.68 Mn |
| Sep 30, 2024 | -183.12 Mn |
| Jun 30, 2024 | -188.50 Mn |
| Mar 31, 2024 | -201.00 Mn |
| Dec 31, 2023 | -200.02 Mn |
| Sep 30, 2023 | -202.19 Mn |
| Jun 30, 2023 | -204.78 Mn |
| Mar 31, 2023 | -212.66 Mn |
| Dec 31, 2022 | -217.48 Mn |
| Sep 30, 2022 | -220.10 Mn |
| Jun 30, 2022 | -225.79 Mn |
| Mar 31, 2022 | -231.82 Mn |
| Dec 31, 2021 | -236.98 Mn |
| Sep 30, 2021 | -238.90 Mn |
| Jun 30, 2021 | -315.30 Mn |